{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:38:31Z","timestamp":1791005911163,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:56:00Z","timestamp":1691801760000},"page":"63-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Muhammad Salman","family":"Faisal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto C.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib1","first-page":"1","article-title":"Primary biliary cirrhosis","volume":"61","author":"Dauphinee","year":"1949","journal-title":"Can Med Assoc J"},{"issue":"11","key":"10.1016\/j.cld.2023.06.005_bib2","first-page":"1671","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"64","author":"Beuers","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cld.2018.03.001","article-title":"Changes in the epidemiology of primary biliary cholangitis","volume":"22","author":"Lleo","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2023.06.005_bib5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2017.10.018","article-title":"Factors associated with prevalence and treatment of primary biliary cholangitis in United States health systems","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.1840120116","article-title":"The demography of primary biliary cirrhosis in Ontario, Canada","volume":"12","author":"Witt-Sullivan","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.005_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0168-8278(97)80444-8","article-title":"Prevalence of familial disease in primary biliary cirrhosis in Italy","volume":"26","author":"Floreani","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2023.06.005_bib8","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1111\/liv.12479","article-title":"Geoepidemiology and space\u2013time analysis of Primary biliary cirrhosis in Crete, Greece","volume":"34","author":"Koulentaki","year":"2014","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib9","first-page":"927","article-title":"Low prevalence of primary biliary cirrhosis in Victoria, Australia","volume":"36","author":"Watson","year":"1995","journal-title":"Melbourne Liver Group"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cld.903","article-title":"PBC: No longer a western disease?","volume":"16","author":"Tanaka","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"8","key":"10.1016\/j.cld.2023.06.005_bib11","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory-based study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","article-title":"Population-based epidemiology of primary biliary cirrhosis in South Korea","volume":"43","author":"Kim","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib13","first-page":"24","article-title":"A\u00a0cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid","volume":"15","author":"Sakauchi","year":"2005","journal-title":"J\u00a0Epidemiol"},{"issue":"Suppl. 2","key":"10.1016\/j.cld.2023.06.005_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000440754","article-title":"Geoepidemiology, genetic and environmental risk factors for PBC","volume":"33","author":"Zhang","year":"2015","journal-title":"Dig Dis"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib15","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study","volume":"50","author":"Myers","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.005_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.06.005_bib18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","article-title":"Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.06.005_bib19","doi-asserted-by":"crossref","unstructured":"Lleo A, Wang G-Q, Gershwin ME, Hirschfield GMJTL. Primary biliary cholangitis. 2020;396(10266):1915-1926.","DOI":"10.1016\/S0140-6736(20)31607-X"},{"issue":"4","key":"10.1016\/j.cld.2023.06.005_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/26.4.830","article-title":"Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England","volume":"26","author":"Metcalf","year":"1997","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib22","first-page":"124","article-title":"A\u00a0study of antimitochondrial antibodies in a random population in Estonia","volume":"92","author":"Turchany","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","article-title":"Familial primary biliary cirrhosis reassessed: a geographically-based population study","volume":"30","author":"Jones","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.06.005_bib25","first-page":"189585","article-title":"Primary biliary cirrhosis: family stories","volume":"2011","author":"Smyk","year":"2011","journal-title":"Autoimmune Dis"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","article-title":"Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis","volume":"46","author":"Lazaridis","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.06.005_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-12-110","article-title":"Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates","volume":"12","author":"Mantaka","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun"},{"issue":"4","key":"10.1016\/j.cld.2023.06.005_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"24","key":"10.1016\/j.cld.2023.06.005_bib31","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib32","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1038\/ncomms14828","article-title":"A\u00a0genome-wide association study identifies six novel risk loci for primary biliary cholangitis","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.cld.2023.06.005_bib33","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDC-E2\u2013specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.cld.2023.06.005_bib34","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/apt.16023","article-title":"Pathophysiology and management of primary biliary cholangitis","volume":"52","author":"Leung","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.cld.2023.06.005_bib35","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T\u00a0cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis","volume":"102","author":"Shimoda","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib36","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.gastro.2003.07.013","article-title":"Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis","volume":"125","author":"Kamihira","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.06.005_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2012.12.007","article-title":"Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA","volume":"41","author":"Leung","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib38","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.13198","article-title":"Pathogen infections and primary biliary cholangitis","volume":"195","author":"Tanaka","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.cld.2023.06.005_bib40","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","article-title":"Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis","volume":"124","author":"Shimoda","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.06.005_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","article-title":"Extrahepatic autoimmune conditions associated with primary biliary cirrhosis","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jcla.20130","article-title":"Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis","volume":"20","author":"Bizzaro","year":"2006","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajg.2016.479","article-title":"Thyroid dysfunction in primary biliary cholangitis: a comparative study at two European centers","volume":"112","author":"Floreani","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2023.06.005_bib45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.20276","article-title":"Quality of life in patients with primary biliary cirrhosis","volume":"40","author":"Poupon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.005_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbacli.2014.04.001","article-title":"Association of mitochondrial dysfunction and fatigue: a review of the literature","volume":"1","author":"Filler","year":"2014","journal-title":"BBA Clin"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.21230","article-title":"Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence","volume":"44","author":"Newton","year":"2006","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2023.06.005_bib48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cgh.2008.04.013","article-title":"Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis","volume":"6","author":"Hollingsworth","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2023.06.005_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000440757","article-title":"Fatigue in primary biliary cirrhosis: prevalence, pathogenesis and management","volume":"33","author":"Jopson","year":"2015","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2010.05.026","article-title":"The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up","volume":"53","author":"Jones","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2023.06.005_bib51","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1542-3565(03)00134-4","article-title":"Natural history of pruritus in primary biliary cirrhosis","volume":"1","author":"Talwalkar","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib52","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/bjd.17933","article-title":"Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy","volume":"181","author":"Hussain","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cld.2023.06.005_bib53","doi-asserted-by":"crossref","unstructured":"Danese S, Semeraro S, Papa A, et\u00a0al. Extraintestinal manifestations in inflammatory bowel disease. 2005;11(46):7227.","DOI":"10.3748\/wjg.v11.i46.7227"},{"issue":"8","key":"10.1016\/j.cld.2023.06.005_bib54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1651-2227.1994.tb13165.x","article-title":"Cholestatic pruritus: effect of phototherapy on pruritus and excretion of bile acids in urine","volume":"83","author":"Rosenthal","year":"1994","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1016\/j.cld.2023.06.005_bib55","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.25748","article-title":"Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions","volume":"56","author":"Kremer","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib56","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2023.06.005_bib57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1213\/00000539-199010000-00008","article-title":"Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia","volume":"71","author":"Abboud","year":"1990","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.rhu.0000099623.30805.2f","article-title":"Association of primary biliary cirrhosis and rheumatoid arthritis","volume":"9","author":"Siegel","year":"2003","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1386-6346(01)00138-3","article-title":"Clinicolaboratory characteristics of patients with primary biliary cirrhosis associated with CREST symptoms","volume":"22","author":"Tojo","year":"2002","journal-title":"Hepatol Res"},{"issue":"10","key":"10.1016\/j.cld.2023.06.005_bib60","first-page":"1840","article-title":"The natural history of abdominal pain associated with primary biliary cirrhosis","volume":"89","author":"Laurin","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.005_bib61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.22371","article-title":"Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology","volume":"48","author":"Newton","year":"2008","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2023.06.005_bib62","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/j.1572-0241.2001.04134.x","article-title":"Fat-soluble vitamin levels in patients with primary biliary cirrhosis","volume":"96","author":"Phillips","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"9777","key":"10.1016\/j.cld.2023.06.005_bib63","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib64","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0016-5085(77)80011-5","article-title":"Presentation and course of asymptomatic primary biliary cirrhosis","volume":"72","author":"Long","year":"1977","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2023.06.005_bib65","article-title":"Management of the major complications of cirrhosis: beyond guidelines","volume":"75","author":"Garcia-Pagan","year":"2021","journal-title":"Journal of hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib66","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1572-0241.2006.00423.x","article-title":"Dermatological manifestations in primary biliary cirrhosis patients: a case control study","volume":"101","author":"Koulentaki","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.06.005_bib67","doi-asserted-by":"crossref","unstructured":"Zak A, Zeman M, Slaby A, Vecka MJBPotMFoPUiO. Xanthomas: clinical and pathophysiological relations. 2014;158(2).","DOI":"10.5507\/bp.2014.016"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib68","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group","volume":"30","author":"Poupon","year":"1999","journal-title":"Journal of hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2004.0918.x","article-title":"Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis","volume":"24","author":"Corpechot","year":"2004","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.cld.2023.06.005_bib70","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","article-title":"Overcoming a \"probable\" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature","volume":"42","author":"Bizzaro","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cld.2023.06.005_bib72","doi-asserted-by":"crossref","unstructured":"Mattalia A, Quaranta S, Leung PS, et\u00a0al. Characterization of antimitochondrial antibodies in healthy adults. 1998;27(3):656-661.","DOI":"10.1002\/hep.510270303"},{"key":"10.1016\/j.cld.2023.06.005_bib73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00535-003-1285-6","article-title":"Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture","volume":"39","author":"Shibata","year":"2004","journal-title":"J\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib74","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib76","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.06.005_bib77","doi-asserted-by":"crossref","unstructured":"Taal B, Schalm S, De Bruyn A, De Rooy F, Klein FJCCA. Serum IgM in primary biliary cirrhosis. 1980;108(3):457-463.","DOI":"10.1016\/0009-8981(80)90353-8"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib78","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis","volume":"30","author":"Poupon","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.06.005_bib79","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2006.11.036","article-title":"Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review","volume":"194","author":"Sorokin","year":"2007","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib80","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib81","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"issue":"11","key":"10.1016\/j.cld.2023.06.005_bib83","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib84","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib85","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response","volume":"60","author":"Trivedi","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2\u20133","key":"10.1016\/j.cld.2023.06.005_bib86","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","article-title":"Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis","volume":"48","author":"Rong","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib87","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.06.005_bib88","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib89","first-page":"30","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid","volume":"16","author":"Sakauchi","year":"2006","journal-title":"J\u00a0Epidemiol"},{"issue":"1","key":"10.1016\/j.cld.2023.06.005_bib90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000478-199401000-00009","article-title":"Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis","volume":"18","author":"Taylor","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.cld.2023.06.005_bib91","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00365521.2015.1132337","article-title":"Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis","volume":"51","author":"Juliusson","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2023.06.005_bib92","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.25511","article-title":"Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis","volume":"55","author":"Jin","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2023.06.005_bib93","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2013.12.010","article-title":"Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics","volume":"12","author":"Levy","year":"2014","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612300079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612300079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:01:39Z","timestamp":1761069699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932612300079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S108932612300079X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}